Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BHVN
#2162
Biohaven Ltd.
10.295
0
USD
-1.53%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.53%
Monthly Change
+5.70%
6 month change
-39.23%
Year Change
-39.23%
Previous Close
10.455
0
Open
10.315
0
Bid
Ask
Low
10.280
0
High
10.315
0
Volume
119
Markets
US Stock Market
Healthcare
BHVN
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
68.21 M
81.58 M
102.05 M
150.42 M
—
Valuation ratios
Enterprise value
715.99 M
3.17 B
3.71 B
1.71 B
7.32 B
Price to earnings ratio
-1.06
-7.32
-4.02
-1.65
-8.12
Price to sales ratio
—
-38.27 K
—
—
—
Price to cash flow ratio
-2.03
-9
-5.85
-1.99
-9.91
Price to book ratio
1.12
6.98
8.05
23.33
27.94
Enterprise value to EBITDA ratio
—
-7.39
-4.23
-2.38
-9.18
Profitability ratios
Return on assets %
-0.86
-0.8
-1.38
-1.64
-1.59
Return on equity %
-1.06
-0.95
-2
-14.19
4.99
Return on invested capital %
-1 605.19
-1 597.69
-2 986.34
-2 444
-2 432.2
Gross margin %
—
100
—
—
—
Operating margin %
—
559.04 K
—
—
—
EBITDA margin %
—
550.28 K
—
—
—
Net margin %
—
523.29 K
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
6.52
7.98
3.49
3.18
12.19
Inventory turnover
—
—
—
—
—
Asset turnover
—
-0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
0.53
—
Debt to equity ratio
—
—
—
4.59
—
Long term debt to total assets ratio
—
—
—
0.53
—
Long term debt to total equity ratio
—
—
—
4.59
—
Per share metrics
Operating cash flow per share
-6.65
-4.66
-6.38
-5.66
-5.85
EBIT per share
—
-6.13
-9.7
-6.93
-7.17
EBITDA per share
—
-6.03
-9.62
-6.83
-7.07
Total debt per share
—
—
—
2.22
—
Cash per share
10.4
5.36
5.33
2.97
12.55
Net current asset value per share
13.12
6.21
5.9
3.42
14.87
Tangible book value per share
11.6
5.73
4.42
0.3
3.42
Working capital per share
11.11
5.44
4.21
2.35
9.9
Book value per share
12.04
6.01
4.64
0.48
4.18
News
Raymond James reiterates Strong Buy on Biohaven stock after competitor data
uniQure stock surges 36% on FDA official’s departure
What's Going On With Biohaven Stock On Monday? - Biohaven (NYSE:BHVN)
Biohaven stock price target lowered to $10 by H.C. Wainwright
Leerink Partners reiterates Biohaven Pharma stock Outperform rating
RBC Capital raises Biohaven Pharma stock price target on model tweaks
Piper Sandler reiterates Biohaven stock rating on 2026 catalysts
Piper Sandler reiterates Biohaven stock rating on epilepsy trial
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?
Does Biohaven Ltd. (BHVN) Have the Potential to Rally 82.16% as Wall Street Analysts Expect?
Goldman Sachs initiates coverage on Biohaven Pharma stock with Buy rating
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?